Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Masimo Corp (MASI)

Masimo Corp (MASI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Market News and Commentary

How Is Danaher Corporation’s Stock Performance Compared to other Health Care Stocks?

Headquartered in Washington, D.C., Danaher Corporation (DHR) is a global science and technology powerhouse focused on biotechnology, life sciences, and diagnostics. With a market capitalization of nearly $149 billion, it sits in the “large-cap” territory, a space reserved for companies valued above $10 billion. 

This scale gives Danaher the muscle to build bioprocessing systems, precision laboratory instruments, genomic technologies, and clinical diagnostic platforms that anchor drug development, scientific research, and patient care across hospitals, laboratories, and biopharma facilities worldwide. 

Fundamentals

See More
  • Market Capitalization, $K 9,413,379
  • Shares Outstanding, K 53,714
  • Annual Sales, $ 2,094 M
  • Annual Income, $ -304,900 K
  • EBIT $ 172 M
  • EBITDA $ 276 M
  • 60-Month Beta 1.26
  • Price/Sales 4.34
  • Price/Cash Flow 27.41
  • Price/Book 11.61

Options Overview Details

View History
  • Implied Volatility 6.48% (-0.66%)
  • Historical Volatility 90.12%
  • IV Percentile 0%
  • IV Rank 0.00%
  • IV High 69.93% on 04/07/25
  • IV Low 6.48% on 02/24/26
  • Expected Move (DTE 23) 1.92 (1.10%)
  • Put/Call Vol Ratio 0.65
  • Today's Volume 682
  • Volume Avg (30-Day) 598
  • Put/Call OI Ratio 0.31
  • Today's Open Interest 7,430
  • Open Int (30-Day) 2,385
  • Expected Range 173.43 to 177.27

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 10 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate 1.52
  • Number of Estimates 3
  • High Estimate 1.55
  • Low Estimate 1.46
  • Prior Year 1.80
  • Growth Rate Est. (year over year) -15.56%

Price Performance

See More
Period Period Low Period High Performance
1-Month
129.21 +35.71%
on 02/13/26
175.90 -0.31%
on 02/24/26
+33.89 (+23.96%)
since 01/23/26
3-Month
125.94 +39.23%
on 01/05/26
175.90 -0.31%
on 02/24/26
+29.73 (+20.42%)
since 11/24/25
52-Week
125.94 +39.23%
on 01/05/26
194.88 -10.02%
on 03/03/25
+4.63 (+2.71%)
since 02/24/25

Most Recent Stories

More News
How Is Danaher Corporation’s Stock Performance Compared to other Health Care Stocks?

Danaher Corporation faces near-term relative weakness, but the Street’s conviction suggests recovery ahead.

A : 124.40 (+0.16%)
PINK : 35.78 (-0.28%)
MASI : 175.35 (+0.06%)
DHR : 209.19 (-0.82%)
Are MASI, THR, CECO Obtaining Fair Deals for their Shareholders?

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders.

MASI : 175.35 (+0.06%)
CECE : 11.65 (+2.19%)
THR : 50.48 (+1.43%)
3 Reasons MASI is Risky and 1 Stock to Buy Instead

3 Reasons MASI is Risky and 1 Stock to Buy Instead

MASI : 175.35 (+0.06%)
Masimo Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Masimo Corporation - MASI

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti , LLC (“KSF”) are investigating the proposed sale of Masimo Corporation...

MASI : 175.35 (+0.06%)
DHR : 209.19 (-0.82%)
Is It Too Late to Chase Masimo Stock on Major Danaher News?

Masimo stock rallies as Danaher announces plans of buying the health tech firm for $180 a share in cash. But is there any further upside left in MASI shares?

AAPL : 272.14 (+2.24%)
MASI : 175.35 (+0.06%)
DHR : 209.19 (-0.82%)
3 Reasons MASI is Risky and 1 Stock to Buy Instead

3 Reasons MASI is Risky and 1 Stock to Buy Instead

MASI : 175.35 (+0.06%)
Are MASI, KW, VRME, BKKT Obtaining Fair Deals for their Shareholders?

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders.

MASI : 175.35 (+0.06%)
VRME : 1.0200 (-0.97%)
KW : 10.88 (-0.37%)
BKKT : 10.10 (-0.49%)
Stocks Recover on Strength in Apple and Airline Stocks

The S&P 500 Index ($SPX ) (SPY ) on Tuesday closed up +0.10%, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed up +0.07%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.13%. March E-mini...

ALK : 52.51 (+3.71%)
UAL : 112.59 (+5.06%)
B : 49.71 (+1.00%)
AAPL : 272.14 (+2.24%)
INTU : 358.71 (-0.23%)
HL : 23.64 (-1.46%)
CDE : 24.78 (+1.43%)
FISV : 59.13 (+1.25%)
DDOG : 104.43 (+1.77%)
MASI : 175.35 (+0.06%)
$IUXX : 24,977.04 (+1.09%)
DHR : 209.19 (-0.82%)
SHAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Masimo Corporation (NASDAQ: MASI)

NEW YORK , Feb. 17, 2026 /PRNewswire/ -- Class Action Attorney Juan Monteverde  with Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions...

MASI : 175.35 (+0.06%)
Market Update: Afternoon Gains for Major Indexes

The S&P 500 Index ($SPX ) (SPY ) today is up +0.29%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is up +0.18%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.38%. Major stock indexes, including...

MSTR : 124.61 (+0.73%)
B : 49.71 (+1.00%)
INTU : 358.71 (-0.23%)
HL : 23.64 (-1.46%)
CDE : 24.78 (+1.43%)
FISV : 59.13 (+1.25%)
DDOG : 104.43 (+1.77%)
GLXY : 21.54 (+5.90%)
MASI : 175.35 (+0.06%)
$IUXX : 24,977.04 (+1.09%)
COIN : 162.03 (+1.12%)
DHR : 209.19 (-0.82%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Weakening short term outlook on maintaining the current direction.

Relative Strength is above 70%. The market is in overbought territory. Watch for a potential trend reversal.

See More Share

Business Summary

Masimo Corporation develops, manufactures and markets a family of non-invasive monitoring systems. The Company has two segments: Product Revenues, Royalty & Other revenues. Within Product revenues, the company's flagship - Signal Extraction Tecgnology (SET) Pulse Oximetry - is used to monitor blood oxygen...

See More

Key Turning Points

3rd Resistance Point 176.45
2nd Resistance Point 176.18
1st Resistance Point 175.76
Last Price 175.35
1st Support Level 175.07
2nd Support Level 174.80
3rd Support Level 174.38

See More

52-Week High 194.88
Last Price 175.35
Fibonacci 61.8% 168.54
Fibonacci 50% 160.41
Fibonacci 38.2% 152.28
52-Week Low 125.94

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar